Since August, our teams in France offer a new antiparasitic collar, protecting cats and dogs for up to 8 months from external parasites, addressing the global need to combat vector-borne diseases. In addition to ticks and fleas, it protects dogs against lice and reduces the risk of transmission of leishmania with indirect use on the vector. This new solution that supports continuum of care will progressively be available in other European countries, starting with Germany, Netherlands and Slovenia.

Starting September 2025, our teams will be offering Vikaly to European professionals and pet owners. This disruptive innovation, at the crossroads of our expertise in veterinary medicine and animal nutrition, foreshadows the emergence of a new therapeutic model, better adapted to daily constraints, aligned with contemporary veterinary practices, the expectations of pet owners, and animal welfare. Designed, developed, and manufactured in France, Vikaly demonstrates the commitment of our teams and our ability to open new paths in the management of companion animal health.

Find details of the 2025 half-year results